Graves’ Orbitopathy (GO) is a relatively rare and difficult disease to manage. Many of the treatments have not been subjected to rigorous scientific evaluation. A major obstacle to improving the management of this condition is that no individual centre has access to sufficiently large numbers of patients for adequately powered randomised controlled clinical trials (RCTs).

To overcome this problem the EUGOGO Working Group was established in 1999 by nine European Centres in order to join forces and facilitate the implementation of powerful studies. These initiating centres and all those who have joined since it’s inception have long experience in managing patients with Graves’ Orbitopathy within a multidisciplinary framework, have a track record in clinical research in this condition and constitute large regional or national referral centres.

Starting in October 2022, EUGOGO will host a webinar series dedicated to Grave’s Orbitopathy.
Théa supports EUGOGO in this webinar series as a sponsor.

Look forward to the webinar on 13 February 2023:

Graves’ orbitopathy & Myasthenia gravis

Speakers

Onur Konuk, Ankara
Michael Schittkowski, Göttingen

Moderation

Justin McKee, Edinburgh

Co-presentation with Grave’s orbitopathy and Myasthenia Gravis is a rare, but well recognised phenomenon in patients with suspected Grave’s orbitopathy. This combination presents unique diagnostic and therapeutic challenges to the ophthalmologist, endocrinologist and neurologist. The panel will discuss specific considerations and approaches to this important clinical scenario. 

The invitation of the President, Lelio Baldeschi:

Dear Colleagues

The Executive Committee of the European Group on Graves’ Orbitopathy is pleased to invite you to our upcoming EUGOGO webinars.
Each month we aim to share with you our knowledge and experience in diagnosing and treating patients with thyroid eye disease.
We hope that our selection of topics will cover your needs and provide you helpful information for your daily working life.
Looking very much forward to discuss with you different facettes of this challenging disease!

Yours sincerely

Lelio Baldeschi
President of EUGOGO

An application has been made to the EACCME® for CME accreditation of this event.